Carbohydrate based vaccines

FEBS Letters
Johannes F G Vliegenthart

Abstract

In the past decades, a gradual increase in the resistance to antibiotics has been observed, leading to a serious thread for successful treatment of bacterial infections. This feature in addition to difficulties in developing adequate drugs against (tropical) diseases caused by parasites has stimulated the interest in vaccines to prevent infections. In principle, various types of cell surface epitopes, characteristic for the invading organism or related to aberrant growth of cells, can be applied to develop vaccines. The progress in establishing the structure of carbohydrate immuno-determinants in conjunction with improvements in carbohydrate synthesis has rendered it feasible to develop new generations of carbohydrate-based vaccines.

References

Dec 1, 1987·Proceedings of the National Academy of Sciences of the United States of America·M J McConvilleE Handman
Nov 1, 1983·Infection and Immunity·H SnippeJ F Vliegenthart
Jul 1, 1996·Journal of Immunotherapy with Emphasis on Tumor Immunology : Official Journal of the Society for Biological Therapy·G D MacLeanB M Longenecker
May 13, 1999·Proceedings of the National Academy of Sciences of the United States of America·S F SlovinH I Scher
Jul 14, 1999·Biochimie·A Taurog
Jul 26, 2000·Proceedings of the National Academy of Sciences of the United States of America·G F SpäthS M Beverley
Oct 20, 2000·Advances in Carbohydrate Chemistry and Biochemistry·V Pozsgay
Jun 9, 2001·The Journal of Organic Chemistry·M C Hewitt, P H Seeberger
Aug 16, 2002·Nature·Louis SchofieldPeter H Seeberger
Nov 7, 2002·Journal of the American Chemical Society·Michael C HewittPeter H Seeberger
Mar 15, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Adriana CarrLuis Enrique Fernández
Jun 5, 2003·Chemical Communications : Chem Comm·Peter H Seeberger
Jun 20, 2003·The Journal of Biological Chemistry·Françoise Debierre-GrockiegoRalph T Schwarz
Jan 23, 2004·Chemical Society Reviews·Ulrik Boas, Peter M H Heegaard
May 28, 2004·Cell·Brian A CobbDennis L Kasper
Jul 29, 2004·Proceedings of the National Academy of Sciences of the United States of America·Stacy J Keding, Samuel J Danishefsky
Mar 25, 2005·Endocrine-related Cancer·L A EmensE M Jaffee
Apr 7, 2005·Journal of the American Chemical Society·Xinyu LiuPeter H Seeberger
May 17, 2005·Anais Da Academia Brasileira De Ciências·Christopher Jones
Aug 5, 2005·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Alexander H LucasChristopher E Taylor
Sep 13, 2005·Cellular Microbiology·Rick L Tarleton
Jun 30, 1923·The Journal of Experimental Medicine·M Heidelberger, O T Avery

❮ Previous
Next ❯

Citations

Apr 7, 2010·Cellular and Molecular Life Sciences : CMLS·Martin Frank, Siegfried Schloissnig
Jul 4, 2008·Bioconjugate Chemistry·Jeffrey C GildersleeveBenjamin Allred
Feb 18, 2010·Nature Chemistry·Thomas J BoltjeGeert-Jan Boons
Jul 26, 2011·Evidence-based Complementary and Alternative Medicine : ECAM·Hongtao BiYifa Zhou
Jan 28, 2009·Acta Crystallographica. Section D, Biological Crystallography·Thomas Lütteke
Sep 28, 2012·Beilstein Journal of Organic Chemistry·Thomas Lütteke
Dec 5, 2012·Beilstein Journal of Organic Chemistry·Abhijit Sau, Anup Kumar Misra
Mar 16, 2012·Future Medicinal Chemistry·Rachel Hevey, Chang-Chun Ling
Oct 6, 2014·Nature Chemical Biology·Marco CavallariGennaro De Libero
Apr 3, 2012·Journal of Carbohydrate Chemistry·Zhaojun Yin, Xuefei Huang
Aug 20, 2015·Nucleic Acids Research·Philip V Toukach, Ksenia S Egorova
Apr 2, 2008·Expert Review of Vaccines·Oyindasola Oyelaran, Jeffrey C Gildersleeve
Aug 1, 2010·Expert Opinion on Drug Discovery·Laura CipollaNasrin Shaikh
May 23, 2015·Drug Discoveries & Therapeutics·Yan Zhang, Fengshan Wang
Nov 4, 2008·Trends in Biotechnology·Philip R DormitzerRino Rappuoli
Mar 5, 2010·Acta histochemica·Haike GhazarianSteven B Oppenheimer
Feb 18, 2011·Pharmaceutical Biology·Han HanYifa Zhou
Jul 10, 2010·Journal of the American Chemical Society·Matthias A OberliPeter H Seeberger
Apr 27, 2007·Nature·Christopher N ScanlanRaymond A Dwek
Sep 29, 2012·Chemistry : a European Journal·Robin DalyEoin M Scanlan
Jan 16, 2008·Chembiochem : a European Journal of Chemical Biology·Yu RaoGeert-Jan Boons
Apr 24, 2008·Chemistry : a European Journal·Adeline MiermontXuefei Huang
Oct 9, 2012·Macromolecular Bioscience·Rajesh Sunasee, Ravin Narain
Jul 1, 2017·Frontiers in Cellular and Infection Microbiology·Jonnel A Jaurigue, Peter H Seeberger
Oct 14, 2019·Biologicals : Journal of the International Association of Biological Standardization·Shabirul HaqueBansilal Jailkhani
Jun 25, 2020·ACS Infectious Diseases·Maude Cloutier, Charles Gauthier
Dec 4, 2008·Journal of the American Chemical Society·Siwarutt BoonyarattanakalinPeter H Seeberger
Apr 18, 2009·Journal of Natural Products·Jun UzawaKiminori Ushida
Dec 31, 2010·Organic Letters·Elisa DanieliRoberto Adamo
Feb 24, 2011·The Journal of Organic Chemistry·Alphert E ChristinaJeroen D C Codée

❮ Previous
Next ❯

Related Concepts

Related Feeds

Bacterial Pneumonia (ASM)

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Antifungals (ASM)

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.

Antimalarial Agents (ASM)

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Antimalarial Agents

Antimalarial agents, also known as antimalarials, are designed to prevent or cure malaria. Discover the latest research on antimalarial agents here.

Bacterial Pneumonia

Bacterial pneumonia is a prevalent and costly infection that is a significant cause of morbidity and mortality in patients of all ages. Here is the latest research.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Antifungals

An antifungal, also known as an antimycotic medication, is a pharmaceutical fungicide or fungistatic used to treat and prevent mycosis such as athlete's foot, ringworm, candidiasis, cryptococcal meningitis, and others. Discover the latest research on antifungals here.